PLGA Microspheres of hGH of Preserved Native State Prepared Using a Self-Regulated Process

Pharmaceutics
Jebun Nessa DianaTuo Jin

Abstract

The challenges of formulating recombinant human growth hormone (rhGH) into sustained-release polymeric microspheres include two mutual causal factors, protein denaturing by the formulation process and severe initial burst release related with relative high dose. The stabilizers to protect the proteins must not evoke osmotic pressure inside the microspheres, and the contact of the protein with the interface between water and organic solution of the polymer must be minimized. To meet these criteria, rhGH was pre-formulated into polysaccharide particles via an aqueous-aqueous emulsion in the present study, followed by encapsulating the particles into microspheres through a self-regulated process to minimize the contact of the protein with the water-oil interface. Polysaccharides as the protein stabilizer did not evoke osmotic pressure as small sugar stabilizers, the cause of severe initial burst release. Reduced initial burst enabled reduced protein loading to 9% (from 22% of the once commercialized Nutropin depot), which in turn reduced the dosage form index from 80 to 8.7 and eased the initial burst. A series of physical chemical characterizations as well as biologic and pharmacokinetic assays confirmed that the present method i...Continue Reading

References

Jul 1, 1986·Journal of Microencapsulation·N LeelarasameeJ K Ma
Nov 21, 1995·Proceedings of the National Academy of Sciences of the United States of America·S P SchwendemanR Langer
Dec 1, 1996·Journal of Pharmaceutical Sciences·M C HellerT W Randolph
Jan 14, 2000·Nature Biotechnology·G ZhuS P Schwendeman
Feb 21, 2002·Journal of Controlled Release : Official Journal of the Controlled Release Society·Mitsuko TakenagaRie Igarashi
Jun 6, 2002·Critical Reviews in Therapeutic Drug Carrier Systems·Steven P Schwendeman
Jan 18, 2003·Journal of Pharmaceutical Sciences·Koreyoshi ImamuraKazuhiro Nakanishi
Feb 16, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Rong LiuZhi-Guo Su
Sep 15, 2005·The Journal of Clinical Endocrinology and Metabolism·Andrew R HoffmanUNKNOWN Genentech Adult Growth Hormone Deficiency Study Group
Mar 18, 2006·Journal of Controlled Release : Official Journal of the Controlled Release Society·Hong Kee KimTae Gwan Park
Apr 18, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·Tuo JinHua Zhu
Sep 27, 2012·Angewandte Chemie·Samuel E ReinholdSteven P Schwendeman
Jun 15, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Steven P SchwendemanAnna S Schwendeman
Aug 23, 2017·Journal of Controlled Release : Official Journal of the Controlled Release Society·Thavasyappan ThambiDoo Sung Lee
Mar 1, 2019·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Yulong XiaXue Ke
Jan 15, 2020·Journal of Controlled Release : Official Journal of the Controlled Release Society·Nian-Qiu ShiSteven P Schwendeman

❮ Previous
Next ❯

Citations

Jan 27, 2021·Pharmaceutics·Yuyoung Kim, Hongkee Sah

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA
Scanning electron microscopy
size exclusion chromatography
circular dichroism

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.